Andrew Brough — investor profile photo

Andrew Brough

Global Innovation Leader | Shaping the Future of Work, Education & Skills

📍 Greater Melbourne Area, Australia🔄 Updated November 2026💼 3 investments📅 19 years investing🗓 Last invested Mar 2017𝕏 @upgrade_to_unlock
VC🌍 Australia
3
Total investments
0
Early stage
0
Mid stage
1
Late stage
19y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Mar 2017
The Australian Regenerative Medicine Institute is a $153 million medical research centre that officially opened in April 2009. Located at the thriving Monash Biosciences Precinct on the Clayton campus of Monash University, the Australian Regenerative Medicine Institute is a result of the shared vision, ideas and funding of the State Government of Victoria and Monash University. A team of internationally recognised researchers have been recruited to work in ARMI's state of the art research laboratories to provide new advances in regenerative medicine. The Institute’s staff and students focus on unraveling the basic mechanisms of the regenerative process, aiming to eventually enable doctors to prevent, halt and reverse damage to vital organs due to disease, injury or genetic conditions. This work will form the basis of treatments for conditions such as neurodegenerative disorders, diabetes, arthritis, musculo-skeletal and cardiovascular diseases.
late stageResearch
Experience · 7 entries
All (7)
Investments (3)
Founder (2)
Board (3)
2017
Board Member
Mar 2017
The Australian Regenerative Medicine Institute is a $153 million medical research centre that officially opened in April 2009. Located at the thriving Monash Biosciences Precinct on the Clayton campus of Monash University, the Australian Regenerative Medicine Institute is a result of the shared vision, ideas and funding of the State Government of Victoria and Monash University. A team of internationally recognised researchers have been recruited to work in ARMI's state of the art research laboratories to provide new advances in regenerative medicine. The Institute’s staff and students focus on unraveling the basic mechanisms of the regenerative process, aiming to eventually enable doctors to prevent, halt and reverse damage to vital organs due to disease, injury or genetic conditions. This work will form the basis of treatments for conditions such as neurodegenerative disorders, diabetes, arthritis, musculo-skeletal and cardiovascular diseases.
late stageResearch
2011
South Melbourne Market
Board Member
Mar 2011
2008
HopHive.com
Co-Founder & Director
Aug 2008
2007
National Probation Service - London
Board Member
Mar 2007
2001
Lodestone Innovation Partners
Co-founder & Director
Nov 2001
Show all 7 entries ↓
Investment activity
2007–2017 · 3 investments
200712011120171
Recent (last 2 years)Earlier
Investor lists
Lists that match Andrew's portfolio